个人中心| | 帮助
高级检索
当前位置： 首页 > 详情页

Crystal structure and function analysis of 6-phosphogluconate dehydrogenase in Mycobacterium tuberculosis

| 认领 | 导出 | |

文献详情

资源类型：
Pubmed体系：
作者：
Wang Yingzhi[1,2] * ; Ren Xiaoqian[1,2] * ; Li Tao[3] ; Su Dan[2] ; Zhang Rundong[1,2] ;
机构： [1]Department of Ophthalmology, West China Hospital, Sichuan University, Chengdu, 610041, PR China [2]State Key Laboratory of Biotherapy and Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, PR China [3]Cancer Biotherapy Center & Cancer Research Institute, Peking University Cancer Hospital Yunnan, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Kunming, 650100, PR China
出处：
DOI： 10.1016/j.bbrc.2024.150390
ISSN：

关键词： Mycobacterium tuberculosis 6-Phosphogluconate dehydrogenase Crystal structure Enzymatic kinetics

摘要：
6-phosphogluconate dehydrogenase (6PGDH) is an essential enzyme in energy metabolism and redox reactions, and represents a potential drug target for the development of therapies targeting trypanosomes, plasmodium, or other pathogens. Tuberculosis, caused by Mycobacterium tuberculosis, is a contagious disease that severely affects human health, with approximately one-third of the world's population infected. However, the protein structure, exact oligomeric state, and catalytic mechanism of 6PGDH in Mycobacterium tuberculosis (Mt6PGDH) have remained largely unknown. In this study, we successfully purified and determined the structure of Mt6PGDH, revealing its function as a tetramer in both solution and crystal states. Through structural comparisons, we clarified the tetramer formation mechanism and the oligomeric organization of short-chain 6PGDHs. Additionally, we identified key residues for coenzyme recognition and catalytic activity. This work not only deepens our understanding of the enzymatic function of Mt6PGDH but also lays a foundation for the development of drugs targeting this enzyme.Copyright © 2024 Elsevier Inc. All rights reserved.

基金：
National Key R&D programs of China (No. 2017YFA0505900 and 2017YFA0504300), Sichuan Science & Technology Plan Project (No. 2020YJ0209), and National Natural Science Foundation of China (No. 32360046).
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2024]版：
无
最新[2023]版：
大类 | 3 区 生物学
小类 | 3 区 生物物理 4 区 生化与分子生物学
第一作者：
第一作者机构： [1]Department of Ophthalmology, West China Hospital, Sichuan University, Chengdu, 610041, PR China [2]State Key Laboratory of Biotherapy and Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, PR China
共同第一作者：
通讯作者：
通讯机构： [1]Department of Ophthalmology, West China Hospital, Sichuan University, Chengdu, 610041, PR China [2]State Key Laboratory of Biotherapy and Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, PR China
推荐引用方式(GB/T 7714)：
Wang Yingzhi,Ren Xiaoqian,Li Tao,et al.Crystal structure and function analysis of 6-phosphogluconate dehydrogenase in Mycobacterium tuberculosis[J].Biochemical And Biophysical Research Communications.2024,731:150390.doi:10.1016/j.bbrc.2024.150390.
APA：
Wang Yingzhi,Ren Xiaoqian,Li Tao,Su Dan&Zhang Rundong.(2024).Crystal structure and function analysis of 6-phosphogluconate dehydrogenase in Mycobacterium tuberculosis.Biochemical And Biophysical Research Communications,731,
MLA：
Wang Yingzhi,et al."Crystal structure and function analysis of 6-phosphogluconate dehydrogenase in Mycobacterium tuberculosis".Biochemical And Biophysical Research Communications 731.(2024):150390

相关文献

[1]6-Phosphogluconate dehydrogenase promotes glycolysis and fatty acid synthesis by inhibiting the AMPK pathway in lung adenocarcinoma cells [2]Crystal structure of monkeypox H1 phosphatase, an antiviral drug target [3]China's tuberculosis epidemic stems from historical expansion of four strains of Mycobacterium tuberculosis. [4]Design, synthesis and biological evaluation of novel pyrrole derivatives as potential ClpP1P2 inhibitor against Mycobacterium tuberculosis. [5]Immune checkpoint modulating T cells and NK cells response to Mycobacterium tuberculosis infection [6]Structure-Activity Relationship of Novel Pyrimidine Derivatives with Potent Inhibitory Activities against Mycobacterium tuberculosis [7]The putative NAD(P)H Nitroreductase, Rv3131, is the Probable Activating Enzyme for Metronidazole in Mycobacterium Tuberculosis [8]Crystal structure of the novel di-nucleotide cyclase from Vibrio cholerae (DncV) responsible for synthesizing a hybrid cyclic GMP-AMP. [9]A Rationale for Drug Design Provided by Co-Crystal Structure of IC261 in Complex with Tubulin [10]Discovery and biological evaluation of 4,6-pyrimidine analogues with potential anticancer agents as novel colchicine binding site inhibitors

资源点击量：52808 今日访问量：0 总访问量：4561 更新日期：2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持：重庆聚合科技有限公司 地址：成都市人民南路四段55号